-
Eli Crane Defeats Jonathan Nez in Tight Arizona Congressional Race
-
David Walliams Identified as Celebrity in Sexual Misconduct Allegations After Legal Bid
-
Sherilyn Smith Encourages Women to Embrace Scars as Symbols of Resilience
-
Korea's Severe Asthma Patients Blocked from Biologics by Restrictive Reimbursement Rules
-
Belgium Signs Contract for 20 Rheinmetall Skyranger Air Defence Systems
-
Shanghai Science and Technology Museum Signs Pacts With London and Ottawa Institutions at CIIE
-
BioTech Breakthrough Acknowledges Champions Oncology Innovation with the "Contract Research and Development Innovation Award"
-
New Gold IRA Investing Guide Explains How to Buy Gold in an IRA for American Consumers
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 10
-
Fulcrum Metals PLC Announces Fulcrum to Increase Shareholding in Loyalist
-
Spectrocell Strengthens Product Discovery and Customer Engagement with Bioz Badges
-
3D Induced Polarization Survey Identifies a Large Drill Target at East Goldfield
-
Apex Extends Trinity Zone in West Step-out Drilling With 2.52% REO Over 223.3 m and 2.49% REO Over 123.3 m at Rift
-
KIFFIK Biomedical Recognized as Top Biomarker Access Technology 2026 by Life Sciences Review
-
Zomedica Announces "Third Friday at Four" Webinar on November 20, 2026: The People Behind Zomedica - Seven Guiding Principles in Action, and Q3 Financial Results
-
Precigen Posts Strong Q3: PAPZIMEOS Net Revenue Rose 37%; Positive Cash Flow Achieved Ahead of Schedule
-
Geek+ Unveils 24/7 Warehouse Autonomy Plan to Advance Self-Optimizing, Around-the-Clock Operation
-
Gamma Resources Announces Planned Radon Flux Baseline Survey at Mesa Arc Uranium Project in New Mexico, Provides Update on Project Timelines
-
China Explores a New Pathway for Medical AI: Bridging R&D Innovation and Clinical Adoption
-
Critical Elements' 10,000-Meter Summer Drill Program at Rose West Continues to Deliver Positive Results
-
Aztec Drills 70.1 Meters of 0.80 g/t AuEq (0.49 g/t Au and 16.85 g/t Ag) from Surface in TR26-54 at the Tombstone Project, Arizona
-
Silicon Publishing Launches Prism, Bringing AI-Assisted Automation to Database Publishing
-
Zeb Nickel Commences Diamond Drilling at the Zeb Nickel Project
-
Aston Bay Announces Pre-Feasibility Study Results and Maiden Mineral Reserve for the Storm Copper Project, Nunavut
-
Electrovaya to Participate in Upcoming Investor Conferences
-
Moderna to Present at Upcoming Conference in November 2026
-
INEO Invited to 15th Annual ROTH Technology Conference in New York
-
Odyssey Behavioral Healthcare Launches Virtual Intensive Outpatient Mental Health Treatment for Adults
-
Nextech3D.ai to Report Fiscal Second Quarter 2027 Financial Results and Host Investor Webinar on November 19, 2026 at 4:30 PM ET
-
Adcore Reports Third Quarter 2026 Results: Gross Margin Rises to 64%, Operating Loss Halved, Cash Up to $4.3 Million as Restructuring Takes Hold
-
Sterling Metals Announces Fully Allocated Private Placement of Units, Flow-Through Shares and Charity Flow-Through Units
-
Wash100 Award, GovCon Industry's Highest Honor, Opens Nominations for 2027 Season
-
Greene Concepts Highlights Groundwater Resources and Commercial Opportunities
-
SNZweig Forms AEC Industry Advisory Council
-
Allstar Health Brands Confirms MLS NEXT Expansion Bid to Anchor a Permanent Training Structure and a Professional Pathway
-
Securitas Healthcare Introduces a New Era of RTLS Built for the Future of Healthcare Operations
-
Horizon Aircraft Completes Preliminary Design Review of Cavorite X7 Hybrid eVTOL
-
Cardiff Lexington To Report Third Quarter 2026 Financial Results and Host Conference Call on Monday, November 16, 2026
-
ATWEC Technologies, Inc. (OTCID:ATWT) Reports Third Quarter 2026 Revenue of $12.46 Million, Up 37% Year-over-Year
-
ByNext Joins the Bilt Neighborhood: Reaching More Customers by Integrating Its Technology with Bilt Neighborhood OS
-
Your Patients Are Asking AI About You. AimwellBio Lets Every Physician See the Answer, Free.
-
Peraso to Showcase DUNE 60 GHz Wireless Platform at Africa Tech Festival 2026
-
Four Nines Gold Intersects 67 Metres at 1.78 g/t Gold, Reinforing Emerging Gold Corridor at Hayden Hill
-
Medical Care Technologies Inc. (OTCID:MDCE) Subsidiaries to Manage $20 Million in Private Collectibles Assets
-
Opportunistic Trader ETF(WZRD) to Delist and Liquidate
-
LiveOne (Nasdaq: LVO) Releases Preliminary H1 Fiscal 2027 Results: $37.3 Million in Revenue and Record Audio Adjusted EBITDA* of $7.8 Million, Up 619% Year-Over-Year
-
Critics and Listeners Agree: Eylsia Nicolas' "The Wedding Song" Nominated for GlacerFM's Best Pop Song 2026; Second Consecutive Listener's Choice Nomination Follows Widespread Critical Recognition and Growing Global Audience
-
GoodData.AI Launches the Agentic Serving Plane, a New Category of Enterprise Data Infrastructure for AI Agents
-
Guard Home Warranty Launches Claims 2.0: A Real US-Based Person in 16 Seconds, Claims Reimbursed Instantly
-
Envision Pharma Group appoints Leigh Anne Siino as Senior Vice President of Commercial, Two Labs and Riparian
Organto Foods Announces Fiscal 2024 Financial Results
Fourth Quarter 2024 Results Demonstrate Building Momentum in Business
TORONTO, ON AND BREDA, THE NETHERLANDS / ACCESS Newswire / April 28, 2025 / Organto Foods Inc. (TSX-V:OGO)(OTCQB:OGOFF)(FSE:OGF) ("Organto" or "the Company"), is pleased to announce its audited financial results for the year ended December 31, 2024. All amounts are expressed in Canadian dollars and in accordance with International Financial Reporting Standards (IFRS), except where specifically noted.
"2024 was a year of significant restructuring and realignment for our Company as we positioned our business for sustained growth and stability, and a clear path to profitability. We have made excellent progress with these goals by streamlining our product portfolio, refocusing our go-to-market strategies and reducing costs via both ongoing internal reorganization and the sale of three operating subsidiaries. As we entered the back half of 2024, the performance of our business has accelerated, with strong sales and gross margin growth being realized on a streamlined cost base. These accomplishments have propelled us into 2025 where we continue to see strong positive momentum with a focus on positive cash flow. When combined with the recent completion of our private placement and shares for debt settlements, and the expected conversion of our outstanding convertible debentures to equity in the coming days, we are very excited by our future prospects. We remain intently committed to building a world-class foods company serving growing healthy foods markets, with the goal of creating long-term value for our operating partners, customers, team members and shareholders. We appreciate the support and understanding we have received from so many of our shareholders, debenture holders and key operating partners and are most confident that we are well positioned for a successful future."
Fiscal 2024 Results Overview
Fiscal 2024 sales of $20.7 million versus $14.0 million in the prior year, an increase of approximately 48%. Sales have increased throughout the year as new business has been on-boarded and existing customers have expanded their sales over the course of the year. Q-4 sales were the largest quarterly sales of the year and largest ever for our restructured operations post our sale of subsidiaries in June 2024.
Gross profit of $1.8 million or 8.5% of sales, versus $1.3 million or 9.3% of sales in the prior year, an increase of approximately 35% in gross profit dollars. Adjusted gross profit(1) of $1.8 million or 8.6% when accounting for the impact of realized gains on derivatives versus 8.4% in the prior year.
Cash operating expenses of $3.3 million or 15.8% of sales versus $2.3 million or 16.6% of sales in the prior year. Operating expenses have stabilized following the sale of the subsidiaries in Q-2 2024 and reflect the increased costs of operating that were previously borne by the sold subsidiaries. YTD costs include approximately $217,000 of legal and listing fees related to restructuring and re-listing activities and a one-time management fee bonus accrual of $246,600 related to past services.
Loss from operations of $2.4 million versus a loss of 1.7 million in the prior year. Loss from operations in 2024 includes one-time non-cash stock-based compensation of $0.6 million and management fee bonuses and restructuring costs of $0.5 million.
Adjusted loss from operations of $1.3 million versus $1.8 million in the prior year when adjusted for one-time cash stock compensation expense, management fees, restructuring costs and realized gains/losses on derivatives.
Net loss from continuing operations of $3.3 million versus a loss in the prior year of $5.6 million driven by improved operating earnings, as well as decreased interest and accretion costs as convertible debentures were already accreted to face value in 2023 for the majority ($9.6 million of the total $10.6 million) of the debentures offset by one-time stock based compensation costs of $0.6 million and costs related to restructuring of $0.5 million.
Gain on dissolution of subsidiary of $0.4 million related to the wind-up of our Argentina subsidiary.
Gain on sale of subsidiaries of $2.6 million related to the sale of Organto Europe BV, BeeOrganic BV and Fresh Organic Choice BV in June 2024.
Net loss including discontinued operations of $2.0 million in 2024 versus a net loss including discontinued operations of $13.4 million in 2023.
Fourth Quarter 2024 Results Overview
Sales of approximately $6.5 million versus $3.1 million in the prior year, an increase of approximately 107%. Average monthly sales in Q-4 2025 of $2.15 million versus average monthly sales in Q-3 2024 of $1.74 million, an increase of approximately 24% versus the Q-3 average, with the increase driven primarily by increased sales of bananas and despite ongoing liquidity challenges. Q-4 sales are the largest quarterly sales of the year and largest ever for our restructured operations post our sale of subsidiaries in June 2024.
Gross profit dollars of $0.6 million or 9.1% of sales, versus $0.3 million or 9.1% of sales in the prior year, an increase of 107% in gross profit dollars. Gross profit dollars represent the largest quarterly gross profit dollars ever for our restructured operations post the sale of subsidiaries in June 2024. Adjusted gross profit(1) of $0.7 million or 10.7% when accounting for the impact of realized gains on derivatives versus 8.2% in the prior year.
Cash operating expenses of $1.2 million or 19.3% of sales versus $0.8 million or 24.2% of sales in the prior year. Operating expenses have now stabilized following the sale of the subsidiaries and now include operating costs that were previously included in the results of the subsidiaries that were sold. Q-4 cash operating costs include approximately $108,000 of legal and listing fees related to restructuring and re-listing activities and a one-time management fee bonus accrual of $246,600 related to past services.
Loss from operations of $1.3 million versus $0.6 million in the prior year. Adjusted loss from operations of $0.3 million when adjusted for realized gain on derivatives, one time stock-based compensation and management fees and the costs of restructuring versus a loss of $0.6 million in the prior year when adjusted for a realized loss on derivatives).
Net loss for the quarter, including discontinued operations, was $1.7 million versus $7.5 million in the prior year.
The Company's filings including Audited Financial Statements and accompanying Management's Discussion and Analysis for the year ended December 31, 2024 at www.SEDARplus.ca or at the Company's website at www.organto.com under the Investors tab.
ON BEHALF OF THE BOARD,
Steve Bromley
Chair and Chief Executive Officer
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.
For more information contact:
Investor Relations
[email protected]
John Rathwell, Senior Vice President, Corporate Development and Investor Relations
647 629 0018
The information presented herein refers to the non-IFRS financial measure of adjusted gross profit. We hedge currencies for certain product categories where either the supply or sales commitments are fixed in foreign currencies. The gains and losses from these hedging activities are combined with gross profit to determine adjusted gross profit. This measure is not a recognized measure under IFRS and does not have a standardized meaning prescribed by IFRS. Non-IFRS financial measures should not be considered in isolation nor as a substitute for analysis of the Company's financial information reported under IFRS and are unlikely to be comparable to similar measures presented by other issuers. Rather, these measures are provided as additional information to complement those IFRS measures by providing further understanding of the Company's results of operations from management's perspective and thus highlight trends in its business that may not otherwise be apparent when relying solely on IFRS measures. The Company believes that securities analysts, investors and other interested parties frequently use non-IFRS financial measures in the evaluation of the Company. The Company's management also uses non-IFRS financial measures to facilitate operating performance comparisons from period to period and to prepare annual operating budgets and forecasts.
ABOUT ORGANTO
Organto is an integrated provider of branded, private label, and distributed organic and non-GMO fruit and vegetable products using a strategic asset-light business model to serve a growing socially responsible and health-conscious consumer around the globe. Organto's business model is rooted in its commitment to sustainable business practices focused on environmental responsibility and a commitment to the communities where it operates, its people, and its shareholders.
FORWARD LOOKING STATEMENTS
This news release may include certain forward-looking information and statements, as defined by law including without limitation Canadian securities laws and the "safe harbor" provisions of the US Private Securities Litigation Reform Act of 1995 ("forward-looking statements"). In particular, and without limitation, this news release contains forward-looking statements respecting Organto's business model and markets; Organto's belief that the while there is still work to be done, the Company has made solid progress in the restructuring and realignment of its business focused on a clear path to profitability, sustained growth and long-term stability; Organto's belief that the impact of these restructuring efforts are will continue to become apparent in the financial results of the Company; Organto's belief that the combination of financing and debt restructuring efforts combined with strong sales and margin growth on a streamlined cost base positions the Company for an exciting future; Organto's belief that it remains focused on building a world class company focused on growing healthy foods markets with the gaol of building shareholder value; management's beliefs, assumptions and expectations; and general business and economic conditions. Forward-looking statements are based on a number of assumptions that may prove to be incorrect, including without limitation assumptions about the following: the ability and time frame within which Organto's business model will be implemented and product supply will be increased; cost increases; dependence on suppliers, partners, and contractual counter-parties; changes in the business or prospects of Organto; unforeseen circumstances; risks associated with the organic produce business generally, including inclement weather, unfavorable growing conditions, low crop yields, variations in crop quality, spoilage, import and export laws, and similar risks; transportation costs and risks; general business and economic conditions; and ongoing relations with distributors, customers, employees, suppliers, consultants, contractors, and partners. The foregoing list is not exhaustive and Organto undertakes no obligation to update any of the foregoing except as required by law.
SOURCE: Organto Foods, Inc.
View the original press release on ACCESS Newswire
F.Bennett--AMWN